15138713

Source:http://linkedlifedata.com/resource/pubmed/id/15138713

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007600, umls-concept:C0008838, umls-concept:C0302592, umls-concept:C0596402, umls-concept:C1123005, umls-concept:C1280500, umls-concept:C1518174
pubmed:issue	6
pubmed:dateCreated	2004-5-12
pubmed:abstractText	We investigated the ability of the novel pure antiestrogen ICI 182,780 to modulate the cytotoxic effects of cisplatin in several cervical cancer cell lines.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7806519
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/1,5-bis(2-methoxy-4-nitro-5-sulfophe..., http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Estradiol, http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Formazans, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Neoplasm, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone, http://linkedlifedata.com/resource/pubmed/chemical/fulvestrant
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0344-5704
pubmed:author	pubmed-author:CerbónMarcoM, pubmed-author:García-LópezPatriciaP, pubmed-author:Mohar-BetancourtAlejandroA, pubmed-author:Pérez-CárdenasEnriqueE, pubmed-author:Rodríguez-DorantesMauricioM
pubmed:issnType	Print
pubmed:volume	53
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	533-40
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:15138713-Antineoplastic Agents, pubmed-meshheading:15138713-Carcinoma, pubmed-meshheading:15138713-Cell Survival, pubmed-meshheading:15138713-Cisplatin, pubmed-meshheading:15138713-Dose-Response Relationship, Drug, pubmed-meshheading:15138713-Drug Screening Assays, Antitumor, pubmed-meshheading:15138713-Drug Synergism, pubmed-meshheading:15138713-Estradiol, pubmed-meshheading:15138713-Estrogen Antagonists, pubmed-meshheading:15138713-Female, pubmed-meshheading:15138713-Flow Cytometry, pubmed-meshheading:15138713-Formazans, pubmed-meshheading:15138713-Gene Expression Regulation, Neoplastic, pubmed-meshheading:15138713-HeLa Cells, pubmed-meshheading:15138713-Humans, pubmed-meshheading:15138713-RNA, Messenger, pubmed-meshheading:15138713-RNA, Neoplasm, pubmed-meshheading:15138713-Receptors, Estrogen, pubmed-meshheading:15138713-Receptors, Progesterone, pubmed-meshheading:15138713-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:15138713-Uterine Cervical Neoplasms
pubmed:year	2004
pubmed:articleTitle	Synergistic effects of ICI 182,780 on the cytotoxicity of cisplatin in cervical carcinoma cell lines.
pubmed:affiliation	División de Investigación Básica, Instituto Nacional de Cancerología. Av. San Fernando # 22, Tlalpan 14000, Apartado Postal 22026 México D.F., Mexico. pgarcia_lopez@yahoo.com.mx
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't